Looking to list your PhD opportunities? Log in here.
About the Project
Cancer stem cells present a huge clinical problem in cancer relapse due to their stem cell-like characteristics including enhanced self-renewal, migration, and resistance to chemotherapy.
Neuroblastoma is a rare type of cancer that mostly affects neonates and young children. Despite the relatively rare occurrence of this cancer, it still represents the most common cancer in children under the age of five years with a poor prognosis due to a lack of understanding in regards to the cellular mechanisms.
This project aims to investigate the stem cell-like properties of neuroblastoma cell-lines that will potentially lead to the uncovering of novel therapeutic targets.
The project will provide training in a wide range of cell, molecular biology and analytical techniques, including but not limited to cell culture, confocal microscopy, PCR, pharmacodynamics, immunoblotting, and immunofluorescence.
Email Now
Why not add a message here
The information you submit to Kingston University will only be used by them or their data partners to deal with your enquiry, according to their privacy notice. For more information on how we use and store your data, please read our privacy statement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Search suggestions
Based on your current searches we recommend the following search filters.
Check out our other PhDs in London, United Kingdom
Check out our other PhDs in United Kingdom
Start a New search with our database of over 4,000 PhDs

PhD suggestions
Based on your current search criteria we thought you might be interested in these.
Uncovering novel molecular targets for cancer chemoprevention in oral squamous cell carcinoma
University of Sheffield
Helminth products as macrophage “trainers”: a novel therapeutic tool for the treatment of immune mediated diseases
Kingston University
Medical and Health Care Studies: Fully Funded Cancer Research Wales PhD Scholarship: Developing Small-Molecule inhibitors of GATA2: A Novel Approach to Target Leukaemia Blasts and Stem Cells in Therapy-Resistant Acute Myeloid Leukaemia
Swansea University